Profil
Dirk Haasner is the founder of 4-Antibody AG.
Formerly, VP-Regulatory, Medical Affairs & Policy at Lundbeck USA Inc. from 2002 to 2015.
Senior Vice President-Global Regulatory Affairs at Ovid Therapeutics, Inc. from 2015 to 2022.
Education includes a graduate degree from the University of Basel, conferred in 1991, and a doctorate from the Basel Institute for Immunology, conferred in 1994.
Tidigare kända positioner av Dirk Haasner
| Företag | Position | Slut |
|---|---|---|
| OVID THERAPEUTICS INC. | Generell Rådgivare | - |
Lundbeck USA Inc. | Generell Rådgivare | 2015-11-01 |
4-Antibody AG
4-Antibody AG Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Grundare | - |
Dirk Haasners utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Ovid Therapeutics, Inc.
Ovid Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides medicines to children and adults with neurological disorders | Health Technology |
4-Antibody AG
4-Antibody AG Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
University of Basel
University of Basel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Basel Institute for Immunology
Basel Institute for Immunology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lundbeck USA Inc. |
















